table of content
1 Introduction to Research & Analysis Reports
1.1 Prescription Dermatological Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prescription Dermatological Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prescription Dermatological Drugs Overall Market Size
2.1 Global Prescription Dermatological Drugs Market Size: 2021 VS 2028
2.2 Global Prescription Dermatological Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Prescription Dermatological Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Prescription Dermatological Drugs Players in Global Market
3.2 Top Global Prescription Dermatological Drugs Companies Ranked by Revenue
3.3 Global Prescription Dermatological Drugs Revenue by Companies
3.4 Global Prescription Dermatological Drugs Sales by Companies
3.5 Global Prescription Dermatological Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Prescription Dermatological Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Prescription Dermatological Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prescription Dermatological Drugs Players in Global Market
3.8.1 List of Global Tier 1 Prescription Dermatological Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Prescription Dermatological Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Prescription Dermatological Drugs Market Size Markets, 2021 & 2028
4.1.2 Anti-acne Drugs
4.1.3 Anti-aging Drugs
4.1.4 Dermatitis Drugs
4.1.5 Hair Loss Drugs
4.1.6 Psoriasis Drugs
4.1.7 Skin Cancer Drugs
4.1.8 Melasma Drugs
4.1.9 Seborrhea Drugs
4.2 By Type - Global Prescription Dermatological Drugs Revenue & Forecasts
4.2.1 By Type - Global Prescription Dermatological Drugs Revenue, 2017-2022
4.2.2 By Type - Global Prescription Dermatological Drugs Revenue, 2023-2028
4.2.3 By Type - Global Prescription Dermatological Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Prescription Dermatological Drugs Sales & Forecasts
4.3.1 By Type - Global Prescription Dermatological Drugs Sales, 2017-2022
4.3.2 By Type - Global Prescription Dermatological Drugs Sales, 2023-2028
4.3.3 By Type - Global Prescription Dermatological Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Prescription Dermatological Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Prescription Dermatological Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Prescription Dermatological Drugs Revenue & Forecasts
5.2.1 By Application - Global Prescription Dermatological Drugs Revenue, 2017-2022
5.2.2 By Application - Global Prescription Dermatological Drugs Revenue, 2023-2028
5.2.3 By Application - Global Prescription Dermatological Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Prescription Dermatological Drugs Sales & Forecasts
5.3.1 By Application - Global Prescription Dermatological Drugs Sales, 2017-2022
5.3.2 By Application - Global Prescription Dermatological Drugs Sales, 2023-2028
5.3.3 By Application - Global Prescription Dermatological Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Prescription Dermatological Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Prescription Dermatological Drugs Market Size, 2021 & 2028
6.2 By Region - Global Prescription Dermatological Drugs Revenue & Forecasts
6.2.1 By Region - Global Prescription Dermatological Drugs Revenue, 2017-2022
6.2.2 By Region - Global Prescription Dermatological Drugs Revenue, 2023-2028
6.2.3 By Region - Global Prescription Dermatological Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Prescription Dermatological Drugs Sales & Forecasts
6.3.1 By Region - Global Prescription Dermatological Drugs Sales, 2017-2022
6.3.2 By Region - Global Prescription Dermatological Drugs Sales, 2023-2028
6.3.3 By Region - Global Prescription Dermatological Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Prescription Dermatological Drugs Revenue, 2017-2028
6.4.2 By Country - North America Prescription Dermatological Drugs Sales, 2017-2028
6.4.3 US Prescription Dermatological Drugs Market Size, 2017-2028
6.4.4 Canada Prescription Dermatological Drugs Market Size, 2017-2028
6.4.5 Mexico Prescription Dermatological Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Prescription Dermatological Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Prescription Dermatological Drugs Sales, 2017-2028
6.5.3 Germany Prescription Dermatological Drugs Market Size, 2017-2028
6.5.4 France Prescription Dermatological Drugs Market Size, 2017-2028
6.5.5 U.K. Prescription Dermatological Drugs Market Size, 2017-2028
6.5.6 Italy Prescription Dermatological Drugs Market Size, 2017-2028
6.5.7 Russia Prescription Dermatological Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Prescription Dermatological Drugs Market Size, 2017-2028
6.5.9 Benelux Prescription Dermatological Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Prescription Dermatological Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Prescription Dermatological Drugs Sales, 2017-2028
6.6.3 China Prescription Dermatological Drugs Market Size, 2017-2028
6.6.4 Japan Prescription Dermatological Drugs Market Size, 2017-2028
6.6.5 South Korea Prescription Dermatological Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Prescription Dermatological Drugs Market Size, 2017-2028
6.6.7 India Prescription Dermatological Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Prescription Dermatological Drugs Revenue, 2017-2028
6.7.2 By Country - South America Prescription Dermatological Drugs Sales, 2017-2028
6.7.3 Brazil Prescription Dermatological Drugs Market Size, 2017-2028
6.7.4 Argentina Prescription Dermatological Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Prescription Dermatological Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Prescription Dermatological Drugs Sales, 2017-2028
6.8.3 Turkey Prescription Dermatological Drugs Market Size, 2017-2028
6.8.4 Israel Prescription Dermatological Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Prescription Dermatological Drugs Market Size, 2017-2028
6.8.6 UAE Prescription Dermatological Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Prescription Dermatological Drugs Major Product Offerings
7.1.4 Johnson & Johnson Prescription Dermatological Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Prescription Dermatological Drugs Major Product Offerings
7.2.4 Merck Prescription Dermatological Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 LEO Pharma
7.3.1 LEO Pharma Corporate Summary
7.3.2 LEO Pharma Business Overview
7.3.3 LEO Pharma Prescription Dermatological Drugs Major Product Offerings
7.3.4 LEO Pharma Prescription Dermatological Drugs Sales and Revenue in Global (2017-2022)
7.3.5 LEO Pharma Key News
7.4 Mylan Pharmaceuticals
7.4.1 Mylan Pharmaceuticals Corporate Summary
7.4.2 Mylan Pharmaceuticals Business Overview
7.4.3 Mylan Pharmaceuticals Prescription Dermatological Drugs Major Product Offerings
7.4.4 Mylan Pharmaceuticals Prescription Dermatological Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Mylan Pharmaceuticals Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Prescription Dermatological Drugs Major Product Offerings
7.5.4 Pfizer Prescription Dermatological Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 Roche
7.6.1 Roche Corporate Summary
7.6.2 Roche Business Overview
7.6.3 Roche Prescription Dermatological Drugs Major Product Offerings
7.6.4 Roche Prescription Dermatological Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Roche Key News
7.7 Allergan
7.7.1 Allergan Corporate Summary
7.7.2 Allergan Business Overview
7.7.3 Allergan Prescription Dermatological Drugs Major Product Offerings
7.7.4 Allergan Prescription Dermatological Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Allergan Key News
7.8 Bausch Health
7.8.1 Bausch Health Corporate Summary
7.8.2 Bausch Health Business Overview
7.8.3 Bausch Health Prescription Dermatological Drugs Major Product Offerings
7.8.4 Bausch Health Prescription Dermatological Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Bausch Health Key News
7.9 PharmaDerm Pharmaceuticals
7.9.1 PharmaDerm Pharmaceuticals Corporate Summary
7.9.2 PharmaDerm Pharmaceuticals Business Overview
7.9.3 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Major Product Offerings
7.9.4 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales and Revenue in Global (2017-2022)
7.9.5 PharmaDerm Pharmaceuticals Key News
7.10 Allergan Inamed Corporation
7.10.1 Allergan Inamed Corporation Corporate Summary
7.10.2 Allergan Inamed Corporation Business Overview
7.10.3 Allergan Inamed Corporation Prescription Dermatological Drugs Major Product Offerings
7.10.4 Allergan Inamed Corporation Prescription Dermatological Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Allergan Inamed Corporation Key News
8 Global Prescription Dermatological Drugs Production Capacity, Analysis
8.1 Global Prescription Dermatological Drugs Production Capacity, 2017-2028
8.2 Prescription Dermatological Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Prescription Dermatological Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prescription Dermatological Drugs Supply Chain Analysis
10.1 Prescription Dermatological Drugs Industry Value Chain
10.2 Prescription Dermatological Drugs Upstream Market
10.3 Prescription Dermatological Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prescription Dermatological Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
